COMP <GO>
ACU vs CIX // EV/EBITDA & P/E VALUATION
Acme United Corporation. (NYSE) VS. CompX International Inc. (NYSE) • 15-METRIC TALLY: ACU 3
— CIX 8
▲ EV/EBITDA & P/E VALUATION LEADER: ACU
LAST: $68.11 (+1.89%) • MKT CAP: $261.1M
valuation
11.3x
LAST: $35.68 (-0.75%) • MKT CAP: $440.2M
valuation
15.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACU VS. CIX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACU | CIX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.40% | 30.40% | +9.00 | ACU | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.20% | 21.10% | -11.90 | CIX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 11.3x | 15.0x | -3.70 | ACU | /valuation <GO> |
| Free Cash Flow Yield | 2.90% | 4.34% | -1.44 | CIX | /fcf-yield <GO> |
| Operating Margin | 7.50% | 14.30% | -6.80 | CIX | /operating-margins <GO> |
| Net Profit Margin | 5.20% | 12.30% | -7.10 | CIX | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | 8.50% | -7.40 | CIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.90% | 6.16% | -5.26 | CIX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.72 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.3 | 48.7 | +18.59 | ACU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.8x | 21.0x | +2.80 | CIX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $261.1M | $440.2M | -$179.1M | CIX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACU REV | CIX REV | ACU GROSS % | CIX GROSS % | ACU FCF | CIX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $196.5M | $158.3M | 39.4% | 30.4% | $7.6M | $19.1M |
| FY 2024 | $194.5M | $145.9M | 39.3% | 28.3% | $4.8M | $21.5M |
| FY 2023 | $191.5M | $161.3M | — | — | $28.9M | $25.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACU // BETA —
CIX // BETA —